NEPHROTOXICITY OF CYCLOSPORINE-A AND FK506 - INHIBITION OF CALCINEURIN PHOSPHATASE

被引:0
|
作者
SU, QX
WEBER, L
LEHIR, M
ZENKE, G
RYFFEL, B
机构
[1] UNIV ZURICH,INST TOXICOL,CH-8603 SCHWERZENBACH,SWITZERLAND
[2] ETH ZURICH,SCHWERZENBACH,SWITZERLAND
[3] SANDOZ PHARMA LTD,BASEL,SWITZERLAND
来源
RENAL PHYSIOLOGY AND BIOCHEMISTRY | 1995年 / 18卷 / 03期
关键词
CALCINEURIN; CYCLOSPORINE; FK506; IMMUNOPHILIN; IMMUNOSUPPRESSION; NEPHROTOXICITY; RAPAMYCIN;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cyclosporin A (CsA; 50 mg/kg) and Fujimycine (FK506; 5 mg/kg), but not the related macrolide immunosuppressant rapamycin (5 mg/kg), caused a reduction of glomerular filtration rate, degenerative changes of proximal tubular epithelium, and hypertrophy of the juxtaglomerular apparatus in male Wistar rats when given for 10 days. The molecular mechanisms of CsA and FK506 toxicity were investigated. Cyclophilin A and FK506-binding protein, the main intracytoplasmatic receptors for CsA and FK506, respectively, were each detected in renal tissue extract. tract. In the kidney, high levels of immunoreactive and enzymatically active calcineurin were found which were inhibited by Cyclosporin the immunosuppressants CsA and FK506, but not by rapamycin. Finally, specific immunophilin-drug-calcineurin complexes formed only in the presence of CsA and FK506, but not rapamycin. These results suggest that the nephrotoxic effects of CsA and FK506 is likely mediated through binding to renal immunophilin and inhibiting calcineurin phosphatase.
引用
收藏
页码:128 / 139
页数:12
相关论文
共 50 条
  • [31] CYCLOSPORINE-A AND FK506 REVERSE ANTHRACYCLINE RESISTANCE BY ALTERING THE CELL-CYCLE
    YAMAMOTO, M
    BABA, H
    KUSUMOTO, T
    SAKAGUCHI, Y
    MAEHARA, Y
    KUWANO, M
    SUGIMACHI, K
    ANTI-CANCER DRUGS, 1995, 6 (04) : 570 - 577
  • [32] INTERACTION OF THE PROGESTERONE-RECEPTOR WITH BINDING-PROTEINS FOR FK506 AND CYCLOSPORINE-A
    MILAD, M
    SULLIVAN, W
    DIEHL, E
    ALTMANN, M
    NORDEEN, S
    EDWARDS, DP
    TOFT, DO
    MOLECULAR ENDOCRINOLOGY, 1995, 9 (07) : 838 - 847
  • [33] THE EFFECT OF FK506 AND CYCLOSPORINE-A(CSA) ON THE HUMAN GUT IMMUNE-SYSTEM
    ELITSUR, Y
    LIU, X
    DOSESCU, J
    MOSHIER, JA
    GASTROENTEROLOGY, 1994, 106 (04) : A678 - A678
  • [34] PHARMACOKINETICS OF FK506 FOLLOWING ORAL-ADMINISTRATION - A COMPARISON OF FK506 AND CYCLOSPORINE
    VENKATARAMANAN, R
    JAIN, A
    WARTY, VW
    ABUELMAGD, K
    FURAKAWA, H
    IMVENTARZA, O
    FUNG, J
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 931 - 933
  • [35] RAPAMYCIN, FK506 AND CYCLOSPORINE-A INHIBIT HUMAN PROLACTIN GENE-EXPRESSION
    WERA, S
    BELAYEW, A
    MARTIAL, JA
    FEBS LETTERS, 1995, 358 (02) : 158 - 160
  • [36] PANCREATICODUODENAL ALLOTRANSPLANTATION WITH CYCLOSPORINE AND FK506
    SATO, K
    YAMAGISHI, K
    NAKAYAMA, Y
    YOKOTA, K
    UCHIDA, H
    MASAKI, Y
    WATANABE, K
    ASO, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1074 - 1075
  • [37] COMPARATIVE STUDIES OF FK506 WITH CYCLOSPORINE
    HEWITT, CW
    BLACK, KS
    TRANSPLANTATION, 1988, 46 (03) : 482 - 483
  • [38] THE EFFECT OF THE NEW IMMUNOSUPPRESSIVE DRUG FK506 ON THE FORMATION OF SECONDARY METABOLITES OF CYCLOSPORINE-A
    BAUER, S
    BROCKMOLLER, J
    KEWITZ, H
    ROOTS, I
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 540 - 542
  • [39] COMPARISON OF CONFORMATIONS OF CYCLOSPORINE-A AND MACROLIDE-FK506 FRAGMENTS - LOCALIZATION OF PUTATIVE BINDING-SITES WITH PHOSPHATASE CALCINEURIN
    DENESYUK, AI
    KORPELA, T
    LUNDELL, J
    SARA, R
    ZAVYALOV, VP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) : 280 - 286
  • [40] A calcineurin antifungal strategy with analogs of FK506
    Nambu, Mitchell
    Covel, Jonathan A.
    Kapoor, Mili
    Li, Xiaoming
    Moloney, Molly K.
    Numa, Mehdi M.
    Soltow, Quinlyn A.
    Trzoss, Michael
    Webb, Peter
    Webb, Robert R., II
    Mutz, Mitchell
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2465 - 2471